SARS-CoV-2 RNA controls
Diagnostic research tools you need, now
Synthetic RNA controls enable laboratories to confidently verify and validate assays without the need for live virus handling.
SARS-CoV-2 RNA control, overlapping bases
Traditional synthetic RNA controls
Coverage gaps between non-overlapping fragments
RNA control with overlapping segments
100% bases covered
Codex DNA is providing researchers with critical diagnostic testing tools required for exposing the presence of SARS-CoV-2. Codex DNA SARS-CoV-2 RNA controls are useful as quality control measures for the verification and validation of both next-generation sequencing (NGS) and reverse transcriptase-polymerase chain reaction (RT-PCR) diagnostic assays.
Immediate shipping available: Receive RNA controls 2–3 days from order.
International shipping may vary.
SARS-CoV-2 RNA control, non-overlapping bases
Codex DNA offers fully synthetic RNA controls that consist of six non-overlapping 5 kb fragments of the SARS-CoV-2 genome (NC_045512) and provide coverage of greater than 99.9% of the bases of the viral genome — useful for both RT-PCR and NGS-based assays.
Immediate shipping available: Receive RNA controls 2–3 days from order.
International shipping may vary.
Custom SARS-CoV-2 RNA controls
There are hundreds of SARS-CoV-2 variants known to the scientific community. Codex DNA manufactures custom synthetic RNA controls for any viral reference. Our SARS-CoV-2 tools are built with Gibson Assembly® technology, and are delivered to you in as little as a week, accelerating your SARS-CoV-2 research with unprecedented speed and scale.
Webinar
Learn how Dr. Dan Gibson and team approached completing the world’s first on-demand synthesis of the SARS-CoV-2 full-length, synthetic genome — the causal agent of COVID-19
Application note
Take a deeper look into how the BioXp™ system is enabling researchers around the world to rapidly synthesize SARS-CoV-2 genome parts and accelerate discovery pipelines
Research grant
Codex DNA is donating funds towards the purchase of a BioXp™ system for front-line researchers developing solutions to combat the spread of COVID-19